LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.39 | 770.25 | 4285 | 9326 | 0.4595 | 0.6112 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.61 | 770.25 | 4354 | 9736 | 0.4472 | 0.6052 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.61 | 770.25 | 4101 | 9736 | 0.4212 | 0.5792 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.61 | 770.25 | 4681 | 9736 | 0.4808 | 0.6373 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.83 | 770.25 | 4566 | 10078 | 0.4531 | 0.6156 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.83 | 770.25 | 4385 | 10078 | 0.4351 | 0.5981 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.83 | 770.25 | 4893 | 10078 | 0.4855 | 0.6460 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 70.05 | 770.25 | 4823 | 10413 | 0.4631 | 0.6295 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 70.05 | 770.25 | 4613 | 10413 | 0.4430 | 0.6103 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 70.05 | 770.25 | 5247 | 10413 | 0.5039 | 0.6665 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 72.27 | 770.25 | 5165 | 10730 | 0.4813 | 0.6499 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 72.27 | 770.25 | 4960 | 10730 | 0.4622 | 0.6325 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 72.27 | 770.25 | 5526 | 10730 | 0.5150 | 0.6795 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 74.50 | 770.25 | 5458 | 10991 | 0.4966 | 0.6663 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 74.50 | 770.25 | 5172 | 10991 | 0.4705 | 0.6431 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 74.50 | 770.25 | 5874 | 10991 | 0.5344 | 0.6985 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 76.75 | 770.25 | 5613 | 11262 | 0.4984 | 0.6706 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 76.75 | 770.25 | 5448 | 11262 | 0.4837 | 0.6578 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 76.75 | 770.25 | 6095 | 11262 | 0.5412 | 0.7066 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 78.98 | 770.25 | 5946 | 11518 | 0.5162 | 0.6883 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 78.98 | 770.25 | 5554 | 11518 | 0.4822 | 0.6590 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 78.98 | 770.25 | 6263 | 11518 | 0.5438 | 0.7109 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 81.20 | 770.25 | 6113 | 11766 | 0.5195 | 0.6933 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 81.20 | 770.25 | 5836 | 11766 | 0.4960 | 0.6734 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 81.20 | 770.25 | 6510 | 11766 | 0.5533 | 0.7206 | MN20160304_L02 | N17 |